Comerica Bank Has $13.94 Million Holdings in Cigna Group $CI

Key Points

• Comerica Bank reduced its stake in Cigna Group by 14.7% in Q4, selling 8,758 shares and now holds 50,658 shares valued at approximately $13.94 million.
• Cigna Group beat Q4 expectations with EPS of $8.08 (vs. $7.88 est.) and revenue of $72.5B (vs. $69.53B est.), and set FY2026 guidance at $30.25 EPS—roughly in line with analyst forecasts around $30.32.
• Cigna Group declared a quarterly dividend of $1.56 (annualized $6.24, yield ~2.2%) with an ex-dividend date of June 4 and payment on June 18, while insiders recently sold shares, leaving insider ownership at about 0.60%.

Comerica Bank cut its position in Cigna Group (NYSE:CI - Free Report) by 14.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 50,658 shares of the health services provider's stock after selling 8,758 shares during the quarter. Comerica Bank's holdings in Cigna Group were worth $13,943,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. increased its position in Cigna Group by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider's stock worth $7,203,754,000 after acquiring an additional 414,834 shares during the period. Massachusetts Financial Services Co. MA increased its position in Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider's stock worth $3,249,113,000 after acquiring an additional 903,334 shares during the period. Dodge & Cox increased its position in Cigna Group by 4.0% during the third quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider's stock worth $2,682,231,000 after acquiring an additional 354,615 shares during the period. Sanders Capital LLC increased its position in Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider's stock worth $2,256,469,000 after acquiring an additional 35,150 shares during the period. Finally, Capital Research Global Investors increased its position in Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider's stock worth $916,434,000 after acquiring an additional 1,855,897 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Stock Up 0.7%

Shares of NYSE CI opened at $284.66 on Wednesday. The stock has a market cap of $75.02 billion, a PE ratio of 12.83, a PEG ratio of 0.98 and a beta of 0.26. The business has a fifty day moving average of $274.20 and a two-hundred day moving average of $276.74. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion during the quarter, compared to analysts' expectations of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business's revenue was up 10.4% on a year-over-year basis. During the same period last year, the business earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities research analysts expect that Cigna Group will post 30.32 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group's dividend payout ratio (DPR) is presently 28.13%.

Insiders Place Their Bets

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares of the company's stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares of the company's stock, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on CI shares. Royal Bank Of Canada dropped their target price on shares of Cigna Group from $344.00 to $333.00 and set an "outperform" rating on the stock in a research report on Friday, February 6th. TD Cowen boosted their target price on shares of Cigna Group from $333.00 to $338.00 and gave the stock a "buy" rating in a research report on Monday, February 9th. UBS Group reaffirmed a "buy" rating and set a $375.00 target price on shares of Cigna Group in a research report on Monday, February 9th. Robert W. Baird dropped their target price on shares of Cigna Group from $315.00 to $306.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 15th. Finally, Zacks Research raised shares of Cigna Group from a "strong sell" rating to a "hold" rating in a research report on Monday, January 5th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $332.47.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.